Global Health Programs: Sexually Transmitted Diseases International Activities
The Division of Sexually Transmitted Disease Prevention (DSTDP) at the Centers for Disease Control and Prevention (CDC) provides assistance on clinical, laboratory and programmatic research and evaluation to support global partners in controlling and preventing sexually transmitted infections.
The division’s five global priorities are:
- Global elimination of congenital syphilis,
- STD control for HIV prevention,
- STD prevention in vulnerable populations,
- Rolling out STI vaccines in developing setting, and
- New surveillance & laboratory technologies of emerging concern (e.g., highly resistant gonorrhea).
CDC scientists collaborate with other nations, the World Health Organization (WHO), and other international partners to prevent STDs globally by 1) conducting clinical, laboratory, and programmatic research in support of priority areas such as the global elimination of congenital syphilis and new STD surveillance, 2) supporting the roll out of HPV vaccine in low income, high burden nations, and 3) supporting laboratory technologies of emerging concern, such as global surveillance of highly resistant strains of Neisseria gonorrhea.
Where We Work
- South Africa
- WHO Geneva
Public Health Impact
- Globally, 2.1 million pregnant women are infected with syphilis annually.
- Untreated maternal syphilis accounts for highest STI-related mortality regardless of age.
- Globally, an estimated 6.2% of neonatal deaths and 9.7% of stillbirths are caused by untreated maternal syphilis
- CDC actively supported the successful implementation of the integrated sexual behavioral and biomarker surveillance studies in Honduras (2005), El Salvador (2008), and Nicaragua (2010).
- In 2009-2010, CDC conducted the assessment of STD laboratory capacity at Guatemala, Nicaragua and Panama to decentralize the STD laboratory capacity in the regional and sub-regional levels.
- Mali: implementation of rapid syphilis testing and treatment at 3 antenatal care facilities; tested approximately 1000 women and children in FY 09.